The invention provides novel quinazoline carboxamide azetidine compounds according to Formula (I) and use for the treatment of hyperproliferative diseases, such as cancer.
申请公布号
HUE028967(T2)
申请公布日期
2017.01.30
申请号
HUE11785338
申请日期
2011.11.11
申请人
Merck Patent GmbH
发明人
HUCK, Bayard, R.;JONES, Reinaldo;XIAO, Yufang;NEAGU, Constantin;BANKSTON, Donald;GOUTOPOULOS, Andreas
